Skip to content

Cow's Milk Allergy in Infants With Obstructive Sleep Apnea (OSA)

Cow's Milk Allergy in Infants With Obstructive Sleep Apnea

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00659854
Enrollment
50
Registered
2008-04-16
Start date
2008-04-30
Completion date
Unknown
Last updated
2008-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea Syndrome

Keywords

obstructive sleep apnea syndrome, The study examines the response of infants diagnosed with obstructive sleep apnea syndrome to diet changes

Brief summary

Cow's milk allergy may be involved in the evolution of sleep apnea in infants. The study will assess the effects of specifies diet changes (i.e. non-milk based formula) on the infant. Specifically , infants will be investigated by sleep studies in order to test this hypothesis.

Interventions

DIETARY_SUPPLEMENTNon milk or soy based formula

Babies will be given a non milk or soy base formula for 12 weeks

DIETARY_SUPPLEMENTmilk based formula

Babies will be given a milk based formula for 12 weeks

Sponsors

Soroka University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
2 Months to 24 Months
Healthy volunteers
No

Inclusion criteria

1. Polysomnographically diagnosed OSA 2. Age is 2-24 months 3. Clinical suspicion of milk allergy due to findings in the medical history or physical exam

Exclusion criteria

1. Congenital defects in the pulmonary and gastrointestinal systems 2. Family history of genetic diseases or familial syndromes 3. Infantile asthma.

Design outcomes

Primary

MeasureTime frame
Polysomnographic variables following 12 weeks of non-milk based formula, in comparison to baseline(prior to diet change).24 months

Countries

Israel

Contacts

Primary ContactAviv D Goldbart, MD
avivgold@bgu.ac.il972-8-624-4465

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026